Working… Menu
Trial record 1 of 1 for:    NCT04052204
Previous Study | Return to List | Next Study

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04052204
Recruitment Status : Not yet recruiting
First Posted : August 9, 2019
Last Update Posted : September 2, 2019
EMD Serono
Nektar Therapeutics
Astellas Pharma Inc
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : May 15, 2022
Estimated Study Completion Date : May 15, 2023